Search - tctmd.com

Displaying 321 - 340 of 543

Sort: Relevancy | Date

For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change

News Conference News SCCT 2020

For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change

Yael L. Maxwell

July 28, 2020

THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA

News Daily News

THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA

July 16, 2020

PAD Patients Undertreated With Statins Despite Elevated CV Risk

News Daily News

PAD Patients Undertreated With Statins Despite Elevated CV Risk

July 13, 2020

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

Too Many HF Trial Results Underreported or Never Published

News Daily News

Too Many HF Trial Results Underreported or Never Published

June 23, 2020

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

News Daily News

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

June 08, 2020

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

News Features

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

May 20, 2020

May 2020 News Roundup

News Opinion CV Team Dispatch

May 2020 News Roundup

May 06, 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

News Conference News ACC 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Yael L. Maxwell

April 06, 2020

COVID-19 Drug Candidates May Raise Arrhythmia Risk

News Daily News

COVID-19 Drug Candidates May Raise Arrhythmia Risk

April 03, 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

April 02, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

News Daily News

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

Yael L. Maxwell

March 26, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

March 17, 2020

Olive Oil Consumption Linked to CVD Benefits in the US

News Daily News

Olive Oil Consumption Linked to CVD Benefits in the US

March 09, 2020

TCTMD’s Top 10 Most Popular Stories for February 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

March 02, 2020

Gender Gaps Persist in CV Research, Editorships, and Training

News Daily News

Gender Gaps Persist in CV Research, Editorships, and Training

Yael L. Maxwell

February 20, 2020

News Daily News

Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment

Yael L. Maxwell

February 12, 2020

Researchers Retract Ambulatory BP Monitoring Paper in NEJM Due to Data Problems

News Daily News

Researchers Retract Ambulatory BP Monitoring Paper in NEJM Due to Data Problems

January 31, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

January 31, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.